Gnathostomiasis acquired by British tourists in Botswana. by Herman, Joanna S et al.
Herman, JS; Wall, EC; van-Tulleken, C; Godfrey-Faussett, P; Bailey,
RL; Chiodini, PL (2009) Gnathostomiasis acquired by british tourists
in botswana. Emerging infectious diseases, 15 (4). pp. 594-7. ISSN
1080-6040
Downloaded from: http://researchonline.lshtm.ac.uk/5632/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Gnathostomiasis 
Acquired by 
British Tourists in 
Botswana
Joanna S. Herman, Emma C. Wall, 
Christoffer van Tulleken, Peter Godfrey-Faussett, 
Robin L. Bailey, and Peter L. Chiodini
Infection with Gnathostoma spinigerum has been gen-
erally confi ned to Southeast Asia and Central and South 
America. However, gnathostomiasis was recently found in 
British tourists who had visited Botswana. Consequently, 
travel to Africa should now be considered a risk factor for 
gnathostomiasis.
In recent years, gnathostomiasis has increasingly been found in persons in countries where Gnathostoma spini-
gerum has not been endemic. However, Gnathostoma spp. 
should now be considered emerging imported pathogens. 
Apart from 2 previous reports of gnathostomiasis in Zam-
bia and Tanzania (1), Africa has been considered free of 
this disease. Most persons seen in the West with gnathos-
tomiasis have acquired the infection in Southeast Asia, 
particularly in Thailand and Japan (2–4), or in Central or 
South America, especially Mexico (5,6), where the main 
risk factor is consumption of raw or undercooked fi sh. 
Because few clinicians outside gnathostomiasis-endemic 
regions are familiar with the disease, diagnosis is often 
missed or delayed.
Our report describes a man with confi rmed gnathosto-
miasis and another who probably had the disease; both had 
been on a fi shing trip between Shakawe and Maun in north-
west Botswana. A recent health alert from Johannesburg, 
South Africa, describes 2 clusters of infection with Gna-
thostoma sp. also acquired in the same region in Botswana 
as that visited by our 2 patients (7).
The Cases
The fi rst person evaluated for possible gnathostomiasis 
was a British Caucasian man, 41 years of age, who came 
to the Hospital for Tropical Diseases (HTD) in London 
on September 30, 2008, 3 weeks after his return from the 
Okavango Delta in Botswana. He had been camping, walk-
ing barefoot, and swimming in and drinking river water. On 
several occasions, he had also eaten raw bream. About 2 
weeks later, he reported intermittent abdominal discomfort, 
which was localized, but each morning, the pain moved to a 
different site and was accompanied by a palpable swelling 
over his spleen that resolved after 12 days. Pruritus then 
developed under his left arm and, within 24 hours, a painful 
subcutaneous lump developed on his anterior chest wall.
When he arrived at HTD, he was systemically well but 
had a raised nontender erythematous lesion below his left 
axilla. His eosinophil count was slightly high, 0.69 × 109 
cells/L (reference count <0.4 × 109 cells/L). 
A presumptive diagnosis of migratory helminthic in-
fection was made (gnathostomiasis or larval cestode infec-
tion), and he was treated with ivermectin, 200 μg/kg as a 
single dose, and albendazole, 400 mg 2×/d for 21 days. A 
week later, the lesion had migrated to his neck, but within 
14 days, the lesion and eosinophilia had resolved. His initial 
serologic test result was negative for Gnathostoma spp. A 
subsequent sample was also negative, which may indicate 
that the antibody response had not developed suffi ciently or 
that results were outside the sensitivity range.
A second British Caucasian man came to HTD on Oc-
tober 11, 2008, eleven days after the patient previously de-
scribed, and 5 weeks after the new patient’s return from the 
same trip in Botswana, where he had consumed the same 
foods and participated in the same activities. An erythema-
tous, edematous, and pruritic lump (2 cm) developed above 
his left groin, lasted 4 days, and then subsided. As the lump 
decreased in size, he noticed a histamine-type track (left 
by a larva moving through tissue) toward his ribcage. One 
week later, the track mark had moved further up his chest. 
After another week, he reported a swollen, warm, and itchy 
right knee, which resolved within 24 hours, but 7 days later, 
similar symptoms developed in his right ankle.
He visited HTD again with a serpiginous, raised lesion 
on his back and surrounding erythema and eosinophilia (0.9 
× 109 cells/L). He was treated empirically with albendazole, 
400 mg 2×/d for 21 days, and praziquantel, 20 mg/kg as a 
single dose, for presumptive diagnosis of helminthic infec-
tion. Over the next 6 days, the serpiginous lesion migrated 
over his shoulder and neck, disappeared for 24 hours, then 
reappeared between his eyebrows, moved to his forehead 
and face, and then was felt inside his nose (Figure 1). On 
day 6, a spot developed below his left nostril, from which 
he expressed a larva. He brought it to HTD, where it was 
identifi ed as Gnathostoma spinigerum.
Conclusions
Our patients received a diagnosis of typical cutaneous 
gnathostomiasis, but their lack of travel to a region in which 
the disease was known to be endemic was perplexing. The 
only previous reports of this infection from Africa were in 
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3 persons who ate raw catfi sh from the Rufi ji River in Tan-
zania (1994) and in 2 travelers who ate raw bream from the 
Zambezi River in Zambia (1998) (1). Before these reports, 
all reported cases of gnathostomiasis had been acquired in 
Southeast Asia and Central and South America.
Gnathostomiasis is a nematode infection caused by the 
late third-stage larva (L3) of the helminth Gnathostoma 
spp. A foodborne zoonosis, it is endemic where people eat 
raw or undercooked fi sh that harbor the infectious L3. At 
least 4 species are known to cause human disease, the most 
common being G. spinigerum. Adult nematodes live in the 
stomach of defi nitive fi sh-eating hosts (commonly cats and 
dogs).When feces containing eggs are deposited in water, 
free-swimming fi rst- and then second-stage larvae develop 
(2,8). Ingested by the fi rst intermediate host (a copepod), 
they develop into early L3 forms. Second intermediate 
hosts (freshwater fi sh such as bream, catfi sh, snake-headed 
fi sh, sleeper perch, Nile tilapia, butterfi sh, or eel; frogs; 
snakes; chickens; snails; or pigs) ingest the copepods, lib-
erating the larvae, which encyst in muscle and mature into 
L3 forms. When infected fi sh are eaten by a defi nitive host, 
the larvae mature into adults in ≈6 months (see life cycle of 
G. spinigerum, adapted from an illustration by Sylvia Paz 
Diaz Camacho, available from www.dpd.cdc.gov/dpdx/
HTML/gnathostomiasis.htm). Humans are accidental hosts 
in which the parasite fails to reach sexual maturity. 
Two alternative routes of human infection have been 
suggested: ingestion of water that contains infected cope-
pods or direct skin penetration of food handlers through 
L3-infected meat (2,8). Symptoms in humans occur as 
the larva migrates through tissues, causing cutaneous and/
or visceral larva migrans, which may begin within 24–48 
hours after ingestion of infected meat. Initial nonspecifi c 
symptoms include fever, malaise, nausea, vomiting, diar-
rhea, and epigastric pain lasting 2–3 weeks and usually ac-
companied by a marked eosinophilia. Within 1 month, the 
cutaneous form may develop, with characteristic nonpitting 
edematous migratory swellings that may be painful, prurit-
ic, or erythematous and may last 1–2 weeks. The swellings 
are typically due to 1 larva, occasionally due to 2 or more 
(8). Spontaneous larval extrusion, such as occurred in 1 of 
our patients, has been recorded. 
Visceral gnathostomiasis occurs when the larvae mi-
grate through the internal organs such as the lungs, gut, 
genitourinary tract, eye, ear, and central nervous system. 
This form causes more illness and deaths, with mortality 
rates reported at 8%–25%, than the cutaneous form (9,10). 
Pathogenicity is thought to result from direct mechanical 
injury by the larvae and by their release of secretions and 
excretions, which contain various compounds that cause 
tissue damage (9). The result is characteristic hemorrhagic 
tracts that may be seen at autopsy. Untreated, infected per-
sons may have intermittent symptoms until the larvae die, 
after ≈12 years.
Diagnosis is suggested by eosinophilia, migratory 
lesions, and a history of geographic and food exposure. 
An immunoblot detecting 24-kDa–L3-specifi c antigen is 
considered diagnostic of Gnathostoma sp. and is the most 
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Figure 1. Cutaneous larva migrans on the forehead (A) and shoulder 
(B) of a male British tourist who had visited Botswana.
widely used serologic test because of its high sensitivity 
and specifi city (11; P. Dekumyoy, pers. comm). Some lab-
oratories use an ELISA for immunoglobulin G subclasses 
as a screening test (12). In our fi rst patient, the larva was 
identifi ed based on its morphologic features, including the 
number and size of cephalic hooks and the character and 
extent of spines on its body (Figure 2) (2,13).
For many years, treatment with various drugs was un-
successful, and surgical excision of the larvae was the only 
effective management. Studies in the 1990s confi rmed the 
effi cacy of a 21-day course of albendazole, 400 mg 2×/d 
(14,15), and ivermectin, 0.2 mg/kg immediately or for 2 
consecutive days (15). 
The area for risk of acquiring gnathostomiasis is ex-
panding, and travelers and physicians need to be aware of 
this risk. Eradication of the organism is unlikely given its 
complicated life cycle, but local campaigns and appropriate 
pretravel advice can raise awareness and change people’s 
eating habits. Travelers must realize that culinary adven-
tures on exotic holidays can result in acquiring unwanted 
parasites that may have devastating consequences.
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